经皮穴位电刺激对妇科恶性肿瘤合并高血压患者术前血压的影响

注册号:

Registration number:

ITMCTR2100005408

最近更新日期:

Date of Last Refreshed on:

2021-12-14

注册时间:

Date of Registration:

2021-12-14

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

经皮穴位电刺激对妇科恶性肿瘤合并高血压患者术前血压的影响

Public title:

Effects of transcutaneous electrical acupoint stimulation on preoperative blood pressure in gynecological malignant tumor patients with hypertension

注册题目简写:

English Acronym:

研究课题的正式科学名称:

经皮穴位电刺激对妇科恶性肿瘤合并高血压患者术前血压的影响

Scientific title:

Effects of transcutaneous electrical acupoint stimulation on preoperative blood pressure in gynecological malignant tumor patients with hypertension

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2100054336 ; ChiMCTR2100005408

申请注册联系人:

陈亮

研究负责人:

陈亮

Applicant:

ChenLiang

Study leader:

ChenLiang

申请注册联系人电话:

Applicant telephone:

18940258435

研究负责人电话:

Study leader's telephone:

18940258435

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

chenl_sj@126.com

研究负责人电子邮件:

Study leader's E-mail:

chenl_sj@126.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

辽宁省沈阳市三好街36号

研究负责人通讯地址:

辽宁省沈阳市三好街36号

Applicant address:

36.Sanhao street, Heping District, Shenyang, Liaoning

Study leader's address:

36.Sanhao street, Heping District, Shenyang, Liaoning

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

中国医科大学附属盛京医院

Applicant's institution:

Shengjing hospital of China medical university

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2021PS127J

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件

批准本研究的伦理委员会名称:

中国医科大学附属盛京医院医学伦理委员会

Name of the ethic committee:

Shengjing hospital of China medical university Medical Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2021/4/25 0:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

中国医科大学附属盛京医院

Primary sponsor:

Shengjing hospital of China medical university

研究实施负责(组长)单位地址:

辽宁省沈阳市三好街36号

Primary sponsor's address:

36.Sanhao street, Heping District, Shenyang, Liaoning

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

辽宁

市(区县):

Country:

China

Province:

Liaoning

City:

单位(医院):

中国医科大学附属盛京医院

具体地址:

辽宁省沈阳市三好街36号

Institution
hospital:

Shengjing hospital of China medical university

Address:

36.Sanhao street, Heping District, Shenyang, Liaoning

经费或物资来源:

自筹经费

Source(s) of funding:

Self financing

研究疾病:

术前高血压

研究疾病代码:

Target disease:

Preoperative hypertension

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

其它

Others

研究目的:

妇科恶性肿瘤合并高血压患者,即使血压控制良好,术前也容易发生血压变化,影响围手术期的安全。先前的研究表明,经皮穴位电刺激(tea)可以在麻醉苏醒和拔管期间稳定血压。然而,TEA对术前血压的影响尚未研究。

Objectives of Study:

For gynecological malignant tumor patients with hypertension, even if the blood pressure is well controlled, they are prone to blood pressure changes before operation, which affects the safety of the perioperative period. Transcutaneous electrical acupoint stimulation (TEAS) has been shown to stabilize blood pressure during extubation.However, the effect of teas on preoperative blood pressure has not been studied.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

妇科恶性肿瘤患者和入院前或入院后被诊断为原发性高血压的患者。高血压定义为收缩压(SBP)≥140毫米汞柱和/或舒张压(DBP)≥三天内血压测量值为90 mmHg。美国麻醉师协会(ASA)I-II级。

Inclusion criteria

Patients with gynecological malignant tumors and who were diagnosed with essential hypertension before or after hospital admission. Hypertension was defined as systolic blood pressure (SBP) ≥140 mmHg and/or diastolic blood pressure (DBP) ≥90 mmHg in blood pressure measurements on three different days. American Society of anesthesiologists (ASA) grade I-II.

排除标准:

继发性高血压患者;用于电刺激的部位的皮肤损伤、皮疹或局部感染,或该部位附近存在金属植入物;植入起搏器、心肺起搏器或除颤器;植入电子胰岛素泵或其他类型的电子植入装置;怀孕或哺乳的妇女;体质指数≥30公斤/平方米;中枢神经系统紊乱或精神疾病;或者在一周内接受过电刺激治疗的患者。

Exclusion criteria:

Patients with secondary hypertension; skin damage, rash, or local infection at sites to be used for electrical stimulation or the presence of metal implants near the sites; implantation of pacemakers, cardiopulmonary pacemakers, or defibrillators; implantation of electronic insulin pumps or other types of electronic implanted devices; who were pregnant or lactating; body mass index ≥30 kg/m2; central nervous system disorders or mental illness; or who had been treated with electrical stimulation within a week.

研究实施时间:

Study execute time:

From 2021-12-10

To      2022-05-31

征募观察对象时间:

Recruiting time:

From 2021-12-10

To      2022-05-31

干预措施:

Interventions:

组别:

对照组

样本量:

45

Group:

control group

Sample size:

干预措施:

手术前在非穴位上进行较低的电刺激

干预措施代码:

Intervention:

Low electrical stimulation was performed on non acupoints before operation

Intervention code:

组别:

TEAS组

样本量:

45

Group:

teas group

Sample size:

干预措施:

手术前进行经皮穴位电刺激

干预措施代码:

Intervention:

Percutaneous acupoint electrical stimulation was performed before operation

Intervention code:

样本总量 Total sample size : 90

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

辽宁

市(区县):

Country:

China

Province:

Liaoning

City:

单位(医院):

中国医科大学附属盛京医院

单位级别:

三甲

Institution/hospital:

Shengjing hospital of China medical university

Level of the institution:

Grade III grade A

测量指标:

Outcomes:

指标中文名:

诱导后低血压

指标类型:

主要指标

Outcome:

Postinduction hypotension

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

诱导前高血压

指标类型:

主要指标

Outcome:

Preinduction hypertension

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

none

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

尚未开始

Not yet recruiting

年龄范围:

最小 18
Min age years
最大 100
Max age years

Recruiting status:

Participant age:

性别:

Gender:

女性

Female

随机方法(请说明由何人用什么方法产生随机序列):

使用spss软件进行随机分组

Randomization Procedure (please state who generates the random number sequence and by what method):

SPSS software was used for random grouping

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

可与实验负责人邮件联系,chenl_sj@126.com

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Contact the person in charge of the experiment by email, chenl_ sj@126.com

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

试验中的观察人员会将观察到的指标及时、完整、正确的录入病例记录表中。之后,将数据录入电子数据表,并备份保存。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The observer in the experiment will timely, completely and correctly input the observed indicators into the case record form. After that, the data will be entered into the electronic data sheet, and backup and save.

数据管理委员会:

Data Managemen Committee:

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

国际传统医学临床试验注册平台 京ICP备07032215号-5 提示:推荐使用IE8.0以上版本 宽屏显示分辨率下使用系统